Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG

Affiliations

• ¹ Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA Department of Epidemiology, University of Washington, Seattle, WA, USA rwalter@fredhutch.org.
• ² SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
• ³ Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
• ⁴ Division of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
• ⁵ Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
• ⁶ Department of Medical Oncology, University Hospital, Bern, Switzerland.
• ⁷ Department of Hematology, Cliniques Universitaires Saint-Luc UCL, Brussels, Belgium.
• ⁸ Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
• ⁹ Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.